Mallucci Giovanna, Dickinson Andrew, Linehan Jacqueline, Klöhn Peter-Christian, Brandner Sebastian, Collinge John
Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1, UK.
Science. 2003 Oct 31;302(5646):871-4. doi: 10.1126/science.1090187.
The mechanisms involved in prion neurotoxicity are unclear, and therapies preventing accumulation of PrPSc, the disease-associated form of prion protein (PrP), do not significantly prolong survival in mice with central nervous system prion infection. We found that depleting endogenous neuronal PrPc in mice with established neuroinvasive prion infection reversed early spongiform change and prevented neuronal loss and progression to clinical disease. This occurred despite the accumulation of extraneuronal PrPSc to levels seen in terminally ill wild-type animals. Thus, the propagation of nonneuronal PrPSc is not pathogenic, but arresting the continued conversion of PrPc to PrPSc within neurons during scrapie infection prevents prion neurotoxicity.
朊病毒神经毒性所涉及的机制尚不清楚,而且预防疾病相关形式的朊病毒蛋白(PrP)即PrPSc积累的疗法,并不能显著延长中枢神经系统朊病毒感染小鼠的存活时间。我们发现,在已建立神经侵袭性朊病毒感染的小鼠中耗尽内源性神经元PrPc,可逆转早期海绵状变化,并防止神经元丢失以及疾病进展至临床阶段。尽管细胞外PrPSc积累至晚期患病野生型动物所见的水平,但仍出现了上述情况。因此,非神经元PrPSc的增殖并无致病性,但是在羊瘙痒病感染期间阻止PrPc在神经元内持续转化为PrPSc可预防朊病毒神经毒性。